TIME | TREATMENT | %Viab | %Apoptosis | %Viable_Acro |
---|
0 h | Control | 46.7 ± 4 A | 24.2 ± 4.3 A | 75.4 ± 3.6 A |
| A50 | 58.4 ± 2.7 A | 16 ± 2.4 A | 81.6 ± 2.1 A |
| A65 | 73.9 ± 2.4 *;A | 15 ± 2.8 A | 88 ± 1.4 *;A |
| A80 | 78.1 ± 2.3 *;A | 15.3 ± 2.6 A | 93 ± 1.2 *;A |
2 h | Control | 31.7 ± 3.9 B | 24.1 ± 5.5 A | 55.9 ± 5.2 B |
| A50 | 45.6 ± 3.6 B | 16.9 ± 1.9 A | 64.1 ± 4 B |
| A65 | 50.7 ± 5.1 *;B | 16.8 ± 1.7 A | 68.4 ± 4.3 B |
| A80 | 56.1 ± 4.2 *;B | 19.6 ± 2 A | 75.9 ± 4.2 *;B |
- The table shows: viability (%Viab), apoptosis (%Apoptosis) and viable sperm with intact acrosome (%Viable_Acro). Time: immediately after thawing (0 h) and after an incubation of 2 h at 37 °C (2 h). Treatments: Androcoll-Bear 50% (A50), Androcoll-Bear 65% (A65) and Androcoll-Bear 80% (A80). Data shown are the model-derived mean ± s.e.m
- (*) Asterisks show differences (P < 0.05) between a specific Androcoll-Bear proportion and its Control
- (A,B) Capital letters show differences (P < 0.05) for the same treatment between time (0 and 2 h)